Isolation and Identification of Novel Anti-Diabetic Compounds from Parthenium hysterophorus with Potential Anti-Diabetic Value

Clicks: 1
ID: 309152
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #102 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The global burden of diabetes mellitus continues to escalate, underscoring the urgent need for safer, cost-effective, and mechanism-driven therapeutic alternatives. This study aimed to isolate, identify, and characterize novel anti-diabetic compounds from Parthenium hysterophorus, an ethnomedicinal plant known for its traditional use in managing hyperglycemia. Successive Soxhlet extraction was performed using chloroform, methanol, and water. Preliminary phytochemical screening confirmed the presence of flavonoids and polyphenols across all extracts, with the methanolic extract exhibiting the richest phytoconstituent profile. Bioactivity-guided fractionation via column chromatography led to the isolation of a prominent bioactive fraction (F4), which was subjected to structural elucidation using UV-Vis, FTIR, ¹H NMR, GC-MS, and HPLC. Spectral analyses revealed that the compound was Parthenin, a sesquiterpene lactone bearing characteristic γ-lactone and hydroxyl functionalities. FTIR confirmed key groups (C=O, C=C, –OH), while NMR data supported a pseudoguaianolide skeleton. GC-MS identified several other supportive bioactives including β-sitosterol, phytol, and caryophyllene oxide. HPTLC and HPLC fingerprinting validated the chemical consistency and purity of the isolated compound. In vitro α-amylase inhibition assays demonstrated potent anti-diabetic activity, with the methanolic extract achieving 74.2% inhibition at 100 µg/mL, closely approaching the efficacy of standard Acarbose (84.5%). These results affirm Parthenium hysterophorus as a viable natural source of anti-diabetic agents, with Parthenin as a promising lead molecule.
Reference Key
imported_1761926389_6904dcf5d7160 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ramashish Maurya*, Dr. Ambresh Gupta
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2025
DOI
10.62896/ijpdd.2.6.11
URL
https://ijpdd.org/index.php/files/article/view/303
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.